Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Bristol-Myers Squibb Co.

5 Research Parkway

Wallingford

Connecticut 06492

USA

Name/email consistency: high

Bristol-Myers Squibb Co., 5 Research Parkway, Wallingford, Connecticut 06492, USA. 2009
Bristol-Myers Squibb Co., 311 Pennington-Rocky Hill Road, Hopewell, New Jersey 08540, USA. 2006 - 2009
Bristol-Myers Squibb Pharmaceutical Research Institute, Department of Neuroscience Chemistry, 5 Research Parkway, Wallingford, USA. 2004

8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists. Gilligan, P.J., He, L., Clarke, T., Tivitmahaisoon, P., Lelas, S., Li, Y.W., Heman, K., Fitzgerald, L., Miller, K., Zhang, G., Marshall, A., Krause, C., McElroy, J., Ward, K., Shen, H., Wong, H., Grossman, S., Nemeth, G., Zaczek, R., Arneric, S.P., Hartig, P., Robertson, D.W., Trainor, G. J. Med. Chem. (2009) [Pubmed]
Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists. Gilligan, P.J., Clarke, T., He, L., Lelas, S., Li, Y.W., Heman, K., Fitzgerald, L., Miller, K., Zhang, G., Marshall, A., Krause, C., McElroy, J.F., Ward, K., Zeller, K., Wong, H., Bai, S., Saye, J., Grossman, S., Zaczek, R., Arneric, S.P., Hartig, P., Robertson, D., Trainor, G. J. Med. Chem. (2009) [Pubmed]
Corticotropin-releasing factor receptor antagonists. Gilligan, P.J. Expert. Opin. Ther. Pat (2006) [Pubmed]
Corticotropin-releasing factor antagonists: recent advances and exciting prospects for the treatment of human diseases. Gilligan, P.J., Li, Y.W. Curr. Opin. Drug. Discov. Devel (2004) [Pubmed]